ÂÜÀòÂÒÂ×

Mark joined Immunocore in 2018 to lead the regulatory affairs function. Prior to Immunocore, Mark was Vice President, Global Regulatory Sciences – Oncology at Bristol-Myers Squibb, where he led regulatory approval for oncology projects, including Opdivo, Empliciti, Yervoy and Sprycel . Before joining BMS, Mark spent 22 years at Sanofi-Aventis Pharmaceuticals where he oversaw the US regulatory development group of 70 professionals for all therapeutic areas. Mark earned his master of science degree in Immunology and Biochemistry from SUNY Medical School and his bachelor of science degree in biology/chemistry from Houghton College.